|
Volumn 47, Issue 9, 2000, Pages 866-874
|
Midazolam attenuates ketamine-induced abnormal perception and thought process but not mood changes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
KETAMINE;
MIDAZOLAM;
PLACEBO;
SODIUM CHLORIDE;
ADULT;
ARTICLE;
CLINICAL TRIAL;
COGNITIVE DEFECT;
COLOR VISION;
CONCENTRATION RESPONSE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG INDUCED DISEASE;
ENVIRONMENTAL FACTOR;
HEART RATE;
HUMAN;
HUMAN EXPERIMENT;
MALE;
MOOD;
NORMAL HUMAN;
PERCEPTION DISORDER;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SEDATION;
SOUND;
TIME PERCEPTION;
ADULT;
AFFECT;
ANESTHETICS, DISSOCIATIVE;
ANTI-ANXIETY AGENTS;
BLOOD PRESSURE;
COGNITION DISORDERS;
DOUBLE-BLIND METHOD;
HEART RATE;
HUMANS;
KETAMINE;
MALE;
MIDAZOLAM;
MIDDLE AGED;
NEUROPSYCHOLOGICAL TESTS;
PERCEPTION;
PSYCHOMOTOR PERFORMANCE;
SLEEP STAGES;
THINKING;
|
EID: 0033783945
PISSN: 0832610X
EISSN: None
Source Type: Journal
DOI: 10.1007/BF03019666 Document Type: Article |
Times cited : (20)
|
References (28)
|